Ann Dermatol.  2004 Mar;16(1):39-41. 10.5021/ad.2004.16.1.39.

The Treatment of Cutaneous T-cell Lymphoma with Triple Combination of Interferon alfa, Retinoid, and Photochemotherapy

• Lee JD
• Lee JS
• Cho SH
• Han CH

• KMID: 2158511
• DOI: http://doi.org/10.5021/ad.2004.16.1.39

Abstract

Cutaneous T-cell lymphoma(CTCL) is a rare cutaneous malignant disease and is typically a disease of older adults. There is no optimal treatment for CTCL, which ranges from topical steroid to systemic chemotherapy. Hence until curative therapy is found, therapies that keep CTCL in check and prevent progression to more advanced lymphoma may be desirable alternatives and may presetve quality of life. Herein we report our experience in treating a stage 11B CTCL patient with triple combination of interferon alfa, oral retinoid, and psoralen plus WA(PWA) therapy.

Keyword

Cutaneous T cell lymphoma; Interferon alfa; PUVA; Retinoid

MeSH Terms

Adult
Drug Therapy
Ficusin
Humans
Interferon-alpha*
Interferons*
Lymphoma
Lymphoma, T-Cell, Cutaneous*
Photochemotherapy*
Quality of Life
T-Lymphocytes
Ficusin
Interferon-alpha
Interferons